BR0209282A - Composição antibacteriana - Google Patents
Composição antibacterianaInfo
- Publication number
- BR0209282A BR0209282A BR0209282-4A BR0209282A BR0209282A BR 0209282 A BR0209282 A BR 0209282A BR 0209282 A BR0209282 A BR 0209282A BR 0209282 A BR0209282 A BR 0209282A
- Authority
- BR
- Brazil
- Prior art keywords
- bacterial
- antibacterial composition
- amino acid
- relates
- cytoskeleton
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10121145 | 2001-04-30 | ||
| DE10129870A DE10129870A1 (de) | 2001-04-30 | 2001-06-21 | Antibakterielles Mittel |
| PCT/EP2002/004410 WO2002087554A2 (fr) | 2001-04-30 | 2002-04-22 | Agent antibacterien |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0209282A true BR0209282A (pt) | 2004-07-27 |
Family
ID=26009202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0209282-4A BR0209282A (pt) | 2001-04-30 | 2002-04-22 | Composição antibacteriana |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1397157A2 (fr) |
| JP (1) | JP2004534016A (fr) |
| CN (1) | CN1298739C (fr) |
| AU (1) | AU2002302555B2 (fr) |
| BG (1) | BG108399A (fr) |
| BR (1) | BR0209282A (fr) |
| CA (1) | CA2445995A1 (fr) |
| CZ (1) | CZ20033271A3 (fr) |
| EE (1) | EE200300530A (fr) |
| HU (1) | HUP0401586A3 (fr) |
| IL (1) | IL158627A0 (fr) |
| MX (1) | MXPA03009954A (fr) |
| NZ (1) | NZ529662A (fr) |
| PL (1) | PL366836A1 (fr) |
| RU (1) | RU2003134636A (fr) |
| SK (1) | SK14792003A3 (fr) |
| WO (1) | WO2002087554A2 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10229645A1 (de) * | 2002-07-02 | 2004-05-19 | Kuchenreuther, Ulrich, Dr. | Zellaufschluss von Bakterien |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| ES2650665T3 (es) | 2009-07-31 | 2018-01-19 | Grünenthal GmbH | Método de cristalización y biodisponibilidad |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| WO2012071517A2 (fr) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Nouvelles formes cristallines |
| CN105218668B (zh) * | 2015-10-30 | 2020-03-24 | 山东农业大学 | 马耳他型布氏杆菌的EF-Tu蛋白单克隆抗体MAb及其制备方法与应用 |
| WO2017208070A1 (fr) | 2016-05-31 | 2017-12-07 | Grünenthal GmbH | Acide bisphosphonique et coformeurs avec lysine, glycine, nicotinamide pour le traitement de la polyarthrite psoriasique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0466251A1 (fr) * | 1990-07-10 | 1992-01-15 | Gist-Brocades N.V. | Mutants résistant à l'elfamycine |
| EP1049809B1 (fr) * | 1998-01-23 | 2006-10-25 | bioMerieux B.V. | ARNm de EF-Tu, EN TANT QUE MARQUEUR DE VIABILITE DE BACTERIES |
| US6451556B1 (en) * | 1998-12-21 | 2002-09-17 | Smithkline Beecham Corporation | EF-Tu |
-
2002
- 2002-04-22 CA CA002445995A patent/CA2445995A1/fr not_active Abandoned
- 2002-04-22 JP JP2002584900A patent/JP2004534016A/ja active Pending
- 2002-04-22 AU AU2002302555A patent/AU2002302555B2/en not_active Ceased
- 2002-04-22 BR BR0209282-4A patent/BR0209282A/pt not_active Application Discontinuation
- 2002-04-22 CN CNB028102185A patent/CN1298739C/zh not_active Expired - Fee Related
- 2002-04-22 IL IL15862702A patent/IL158627A0/xx unknown
- 2002-04-22 HU HU0401586A patent/HUP0401586A3/hu unknown
- 2002-04-22 PL PL02366836A patent/PL366836A1/xx unknown
- 2002-04-22 EP EP02730187A patent/EP1397157A2/fr not_active Withdrawn
- 2002-04-22 SK SK1479-2003A patent/SK14792003A3/sk unknown
- 2002-04-22 RU RU2003134636/13A patent/RU2003134636A/ru unknown
- 2002-04-22 MX MXPA03009954A patent/MXPA03009954A/es unknown
- 2002-04-22 EE EEP200300530A patent/EE200300530A/xx unknown
- 2002-04-22 CZ CZ20033271A patent/CZ20033271A3/cs unknown
- 2002-04-22 NZ NZ529662A patent/NZ529662A/en unknown
- 2002-04-22 WO PCT/EP2002/004410 patent/WO2002087554A2/fr not_active Application Discontinuation
-
2003
- 2003-12-01 BG BG108399A patent/BG108399A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2445995A1 (fr) | 2002-11-07 |
| SK14792003A3 (sk) | 2004-07-07 |
| EE200300530A (et) | 2004-04-15 |
| HUP0401586A2 (hu) | 2004-11-29 |
| HUP0401586A3 (en) | 2005-06-28 |
| EP1397157A2 (fr) | 2004-03-17 |
| BG108399A (bg) | 2004-08-31 |
| WO2002087554A2 (fr) | 2002-11-07 |
| PL366836A1 (en) | 2005-02-07 |
| AU2002302555B2 (en) | 2007-08-23 |
| RU2003134636A (ru) | 2005-04-20 |
| WO2002087554A3 (fr) | 2003-01-30 |
| WO2002087554B1 (fr) | 2005-01-27 |
| CN1298739C (zh) | 2007-02-07 |
| IL158627A0 (en) | 2004-05-12 |
| NZ529662A (en) | 2006-08-31 |
| JP2004534016A (ja) | 2004-11-11 |
| CZ20033271A3 (en) | 2004-06-16 |
| CN1518455A (zh) | 2004-08-04 |
| MXPA03009954A (es) | 2005-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9713404A (pt) | ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos. | |
| BRPI0407058A (pt) | Métodos de profilaxia e de tratamento de uma doença, composição farmacêutica, e, uso de um fragmento | |
| HUP0002322A2 (hu) | Multivalens vakcinakészítmény kevert hordozóval | |
| BRPI9915679B8 (pt) | composições e métodos para aumentar a mineralização óssea | |
| DK0625989T3 (da) | DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer | |
| BR0009564A (pt) | Utilização de inibidores da cyp2d6 em terapias de combinação | |
| BRPI0511421A (pt) | composições cosmética e farmacêutica para tratar materiais contendo queratina, uso de composições cosméticas, molécula efetora que liga queratina, uso da mesma, e, processo | |
| BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR0214705A (pt) | Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit | |
| BRPI0413521A (pt) | seqüências de aminoácidos que facilitam a penetração de uma substáncia de interesse nas células e/ou no núcleos celulares | |
| BR9914066A (pt) | Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae | |
| UY24949A1 (es) | Compuestos calcilíticos | |
| BR9714358A (pt) | Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
| PT980263E (pt) | Produto de combinacao que associa um acido nucleico a uma substancia desorganizadora da matriz extracelular para terapia genetica | |
| BR9406689A (pt) | Adenovirus recombinante defectivo utilização deste adenovirus e composição farmacêutica obtida | |
| BR0015698A (pt) | Composições e métodos para tratamento de doenças alérgicas | |
| FR2827866B1 (fr) | Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations | |
| BR0209282A (pt) | Composição antibacteriana | |
| BR0316923A (pt) | Polipeptìdeo mitoneet de membranas mitocondriais, seus moduladores e métodos para utilização do mesmo | |
| BR0305244A (pt) | Processo de isolamento de proteinas de leite a partir de leite e de um soro de leite, fração protéica de leite, associação, composição alimentìcia, kits alimentìcios, utilização de uma fração protéica de leite, composição farmacêutica, e, produto de higiene | |
| BR0014860A (pt) | Métodos para a produção de uma molécula alvo em um animal transgênico e purificação da molécula alvo | |
| DE602004025265D1 (de) | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon | |
| FI972170A (fi) | Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, näitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö | |
| BR0303912A (pt) | Composição para o condicionamento, composição para o condicionamento durável, método para o condicionamento, método para o condicionamento durável, método para o cuidado ou tratamento e kit para o cuidado, tratamento, condicionamento ou condicionamento durável | |
| BR9812773A (pt) | "alfa-amino-epsilon-caprolactamas policìclicas e compostos relacionados" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |